Technical Analysis for HEMO - Hemogenyx Pharmaceuticals Plc
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 4.15 | -3.49% | -0.15 |
HEMO closed down 3.49 percent on Friday, April 16, 2021, on 2.12 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Historical HEMO trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New Downtrend | Bearish | 0.00% | |
| Calm After Storm | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| NR7-2 | Range Contraction | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Below Lower BB | Weakness | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| Down 1% | 1 day ago |
| 3x Volume Pace | 1 day ago |
| 2x Volume Pace | 1 day ago |
| 1.5x Volume Pace | 1 day ago |
| Up 3% | 1 day ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
Hemogenyx Pharmaceuticals Plc, a preclinical-stage biotechnology company, focuses on the discovery, development, and commercialization of novel therapies and treatments for blood diseases. It is developing products for bone marrow/hematopoietic stem cell BM/HSC transplant market, including CDX bi-specific antibody and CAR-T therapy for eliminating relapsed and/or refractory acute myeloid leukaemia, acute lymphoblastic leukaemia, and myelodysplastic syndrome; and Human Postnatal Hemogenic Endothelial Cells, a cell therapy product for BM/HSC transplants. Hemogenyx Pharmaceuticals Plc was founded in 2013 and is headquartered in London, the United Kingdom.
Keywords: Pharmaceutical Biotechnology Medicine Clinic Pharmaceuticals Disease Plants Branches Of Biology Diseases Medical Specialties Plastic Therapy Blood Rtt Dx Therapies Antibody Cell Therapy Refractory Stage Biotechnology Stem Cells Acute Myeloid Leukemia Cell Therapy Product Leukemia
Classification
Keywords: Pharmaceutical Biotechnology Medicine Clinic Pharmaceuticals Disease Plants Branches Of Biology Diseases Medical Specialties Plastic Therapy Blood Rtt Dx Therapies Antibody Cell Therapy Refractory Stage Biotechnology Stem Cells Acute Myeloid Leukemia Cell Therapy Product Leukemia
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 15.3875 |
| 52 Week Low | 1.71 |
| Average Volume | 4,947,269 |
| 200-Day Moving Average | 8.42 |
| 50-Day Moving Average | 6.62 |
| 20-Day Moving Average | 6.68 |
| 10-Day Moving Average | 6.32 |
| Average True Range | 0.84 |
| ADX | 25.75 |
| +DI | 12.32 |
| -DI | 27.23 |
| Chandelier Exit (Long, 3 ATRs ) | 5.49 |
| Chandelier Exit (Short, 3 ATRs ) | 6.56 |
| Upper Bollinger Band | 8.77 |
| Lower Bollinger Band | 4.58 |
| Percent B (%b) | -0.1 |
| BandWidth | 62.66 |
| MACD Line | -0.45 |
| MACD Signal Line | -0.10 |
| MACD Histogram | -0.3429 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 4.66 | ||||
| Resistance 3 (R3) | 4.70 | 4.58 | 4.58 | ||
| Resistance 2 (R2) | 4.58 | 4.45 | 4.56 | 4.55 | |
| Resistance 1 (R1) | 4.36 | 4.37 | 4.30 | 4.32 | 4.52 |
| Pivot Point | 4.24 | 4.24 | 4.21 | 4.22 | 4.24 |
| Support 1 (S1) | 4.02 | 4.11 | 3.96 | 3.98 | 3.78 |
| Support 2 (S2) | 3.90 | 4.03 | 3.88 | 3.75 | |
| Support 3 (S3) | 3.68 | 3.90 | 3.73 | ||
| Support 4 (S4) | 3.64 |
